40 related articles for article (PubMed ID: 8674042)
1. Chromosomal imbalances in papillary renal cell carcinoma: genetic differences between histological subtypes.
Jiang F; Richter J; Schraml P; Bubendorf L; Gasser T; Sauter G; Mihatsch MJ; Moch H
Am J Pathol; 1998 Nov; 153(5):1467-73. PubMed ID: 9811338
[TBL] [Abstract][Full Text] [Related]
2. Unique patterns of allelic imbalance distinguish type 1 from type 2 sporadic papillary renal cell carcinoma.
Sanders ME; Mick R; Tomaszewski JE; Barr FG
Am J Pathol; 2002 Sep; 161(3):997-1005. PubMed ID: 12213728
[TBL] [Abstract][Full Text] [Related]
3. Insights into the Genetic Basis of the Renal Cell Carcinomas from The Cancer Genome Atlas.
Haake SM; Weyandt JD; Rathmell WK
Mol Cancer Res; 2016 Jul; 14(7):589-98. PubMed ID: 27330105
[TBL] [Abstract][Full Text] [Related]
4. Renal Cell Carcinoma in the Era of Precision Medicine: From Molecular Pathology to Tissue-Based Biomarkers.
Signoretti S; Flaifel A; Chen YB; Reuter VE
J Clin Oncol; 2018 Oct; 36(36):JCO2018792259. PubMed ID: 30372384
[TBL] [Abstract][Full Text] [Related]
5. Genetic and Chromosomal Aberrations and Their Clinical Significance in Renal Neoplasms.
Yap NY; Rajandram R; Ng KL; Pailoor J; Fadzli A; Gobe GC
Biomed Res Int; 2015; 2015():476508. PubMed ID: 26448938
[TBL] [Abstract][Full Text] [Related]
6. Genetic architecture of renal cell carcinoma: Do we have to know?
Öztürk H
World J Urol; 2016 Jun; 34(6):765-9. PubMed ID: 26412087
[No Abstract] [Full Text] [Related]
7. Tumour and patient factors in renal cell carcinoma-towards personalized therapy.
Haddad AQ; Margulis V
Nat Rev Urol; 2015 May; 12(5):253-62. PubMed ID: 25868564
[TBL] [Abstract][Full Text] [Related]
8. Chromophobe renal cell carcinoma--chromosomal aberration variability and its relation to Paner grading system: an array CGH and FISH analysis of 37 cases.
Sperga M; Martinek P; Vanecek T; Grossmann P; Bauleth K; Perez-Montiel D; Alvarado-Cabrero I; Nevidovska K; Lietuvietis V; Hora M; Michal M; Petersson F; Kuroda N; Suster S; Branzovsky J; Hes O
Virchows Arch; 2013 Oct; 463(4):563-73. PubMed ID: 23913167
[TBL] [Abstract][Full Text] [Related]
9. Chromophobe renal cell carcinoma: useful diagnostic application of imprint cytology and fluorescence in situ hybridization of chromosomes 10 and 21 in two cases of typical and eosinophilic variants.
Kuroda N; Katto K; Yamaguchi T; Kawada T; Imamura Y; Hes O; Michal M; Shuin T; Lee GH
Med Mol Morphol; 2008 Dec; 41(4):227-32. PubMed ID: 19107613
[TBL] [Abstract][Full Text] [Related]
10. Analysis of the ANA gene as a candidate for the chromosome 21q oral cancer susceptibility locus.
Yamamoto N; Uzawa K; Yakushiji T; Shibahara T; Noma H; Tanzawa H
Br J Cancer; 2001 Mar; 84(6):754-9. PubMed ID: 11259088
[TBL] [Abstract][Full Text] [Related]
11. Allelic imbalance and instability of microsatellite loci on chromosome 1p in human non-small-cell lung cancer.
Gasparian AV; Laktionov KK; Belialova MS; Pirogova NA; Tatosyan AG; Zborovskaya IB
Br J Cancer; 1998 May; 77(10):1604-11. PubMed ID: 9635835
[TBL] [Abstract][Full Text] [Related]
12. Microsatellite allelotyping differentiates chromophobe renal cell carcinomas from renal oncocytomas and identifies new genetic changes.
Nagy A; Buzogany I; Kovacs G
Histopathology; 2004 Jun; 44(6):542-6. PubMed ID: 15186268
[TBL] [Abstract][Full Text] [Related]
13. Allelic losses at chromosome 17p in human renal cell carcinoma are inversely related to allelic losses at chromosome 3p.
Ogawa O; Habuchi T; Kakehi Y; Koshiba M; Sugiyama T; Yoshida O
Cancer Res; 1992 Apr; 52(7):1881-5. PubMed ID: 1348014
[TBL] [Abstract][Full Text] [Related]
14. Molecular pathology of chromophobe renal cell carcinoma: a review.
Yusenko MV
Int J Urol; 2010 Jul; 17(7):592-600. PubMed ID: 20590942
[TBL] [Abstract][Full Text] [Related]
15. Evolving classification of renal cell neoplasia.
Delahunt B; Velickovic M; Grebe SK
Expert Rev Anticancer Ther; 2001 Dec; 1(4):576-84. PubMed ID: 12113090
[TBL] [Abstract][Full Text] [Related]
16. Allelic losses at chromosomes 1p, 2p, 6p, 10p, 13q, 17p, and 21q significantly correlate with the chromophobe subtype of renal cell carcinoma.
Schwerdtle RF; Störkel S; Neuhaus C; Brauch H; Weidt E; Brenner W; Hohenfellner R; Huber C; Decker HJ
Cancer Res; 1996 Jul; 56(13):2927-30. PubMed ID: 8674042
[TBL] [Abstract][Full Text] [Related]
17. Loss of heterozygosity studies and deletion mapping identify two putative chromosome 14q tumor suppressor loci in renal oncocytomas.
Schwerdtle RF; Winterpacht A; Störkel S; Brenner W; Hohenfellner R; Zabel B; Huber C; Decker HJ
Cancer Res; 1997 Nov; 57(22):5009-12. PubMed ID: 9371493
[TBL] [Abstract][Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
